MiMedx Group MDXG Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $30.7M-36.8% | $48.58M+19.0% | $40.83M+27.8% | $31.96M-20.0% | $39.96M-4.9% | ||
| $10.44M-36.3% | $16.4M-12.0% | $18.63M+6.3% | $17.52M+3.9% | $16.86M-0.5% | ||
| -$3.56M+59.2% | -$8.71M+3.1% | -$8.99M-48.8% | -$6.04M+45.4% | -$11.06M+11.3% | ||
| $7.24M+11.1% | $6.52M+80.8% | $3.6M+184% | $1.27M+11.5% | $1.14M+91.4% | ||
| -$9.02M-134% | $26.39M-4.9% | $27.76M+56.8% | $17.7M+176% | $6.41M+151% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $5.77M-34.5% | $8.82M— | —— | —— | —— | ||
| $380K+31.5% | $289K— | —— | —— | —— | ||
| $593K-7.5% | $641K-2.0% | $654K-27.3% | $899K— | —— | ||
| $1.29M+1.8% | $1.26M-1.0% | $1.28M-1.0% | $1.29M-0.9% | $1.3M-0.8% | ||
| $70.58M-4.6% | $74M+9.1% | $67.83M+16.7% | $58.12M-11.3% | $65.52M-1.0% | ||
| $1.23M+18.7% | $1.03M+2.2% | $1.01M+2.1% | $990K+8.1% | $916K-45.6% | ||
| $8.76M+133% | $3.76M-39.9% | $6.26M+95.9% | $3.2M+11.7% | $2.86M-63.6% | ||
| -$12.12M-76.0% | -$6.89M+26.1% | -$9.32M-130% | -$4.06M+0.4% | -$4.08M+57.9% | ||
| $2.56M-17.9% | $3.12M+0.7% | $3.1M-0.9% | $3.12M+6.0% | $2.95M+11.6% | ||
| -$5.12M+5.4% | -$5.41M-3.5% | -$5.23M-19.6% | -$4.37M-20.2% | -$3.64M+89.4% | ||
| $53.34M-13.6% | $61.71M+15.8% | $53.28M+6.9% | $49.83M-14.0% | $57.94M+158% | ||
| -$3.56M+59.2% | -$8.71M+3.1% | -$8.99M-48.8% | -$6.04M+45.4% | -$11.06M+11.3% | ||
| -$2.65M-129% | $8.99M-0.9% | $9.07M+33.1% | $6.81M+109% | $3.26M+12.7% | ||
| $5.77M-34.5% | $8.82M— | —— | —— | —— | ||
| $1.29M+1.8% | $1.26M-1.0% | $1.28M-1.0% | $1.29M-0.9% | $1.3M-0.8% | ||
| $7.24M+11.1% | $6.52M+80.8% | $3.6M+184% | $1.27M+11.5% | $1.14M+91.4% | ||
| —— | $2.09M+32.5% | $1.58M+48.2% | $1.06M+93.1% | $550.75K+1,349% | ||
| $8.76M+133% | $3.76M-39.9% | $6.26M+95.9% | $3.2M+11.7% | $2.86M-63.6% | ||
| $1.23M+18.7% | $1.03M+2.2% | $1.01M+2.1% | $990K+8.1% | $916K-45.6% | ||
| —— | $0+100% | -$14.25K+50.0% | -$28.5K+33.3% | -$42.75K+25.0% | ||
| —— | —— | —— | —— | —— | ||
| $1.43M+10.7% | $1.29M+18.5% | $1.09M+92.3% | $568K+127% | $250K+213% | ||
| —— | —— | —— | —— | —— | ||
| $875K-12.5% | $1M0.0% | $1M0.0% | $1M0.0% | $1M0.0% | ||
| $69.36M-5.0% | $72.97M+9.2% | $66.82M+16.9% | $57.13M-11.6% | $64.6M+0.1% | ||
| $69.36M-5.0% | $72.97M+9.2% | $66.82M+16.9% | $57.13M-11.6% | $64.6M+0.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does MiMedx Group generate?
- MiMedx Group (MDXG) generated $70.6M in operating cash flow over the trailing twelve months.
- What is MiMedx Group's free cash flow?
- After $1.2M of capital expenditures, MiMedx Group's free cash flow was $69.4M over the trailing twelve months, up 7.4% year over year.
- Where does MiMedx Group's cash flow data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
